Credit Suisse’s Adeptus Health Inc ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-26,160
Closed -$47K 4084
2017
Q1
$47K Sell
26,160
-17,395
-40% -$97.7K ﹤0.01% 3748
2016
Q4
$332K Buy
43,555
+33,655
+340% +$619K ﹤0.01% 3613
2016
Q3
$426K Sell
9,900
-4,653
-32% -$210K ﹤0.01% 3503
2016
Q2
$752K Buy
14,553
+4,798
+49% +$288K ﹤0.01% 3162
2016
Q1
$542K Sell
9,755
-24,615
-72% -$1.27M ﹤0.01% 3192
2015
Q4
$1.87M Buy
34,370
+29,341
+583% +$1.87M ﹤0.01% 2327
2015
Q3
$406K Sell
5,029
-9,739
-66% -$1.01M ﹤0.01% 3548
2015
Q2
$1.4M Buy
14,768
+10,241
+226% +$705K ﹤0.01% 2862
2015
Q1
$227K Buy
+4,527
New +$179K ﹤0.01% 4011
2014
Q4
Sell
-12,020
Closed -$299K 4822
2014
Q3
$299K Buy
+12,020
New +$314K ﹤0.01% 3936

Other funds holding ADPT

Credit Suisse's ADPT Position: Q2 2017 in Review

Credit Suisse sold out of Adeptus Health Inc (ADPT) in Q2 2017, closing a stake of 26,160 shares — an estimated $47K sold.

Credit Suisse first reported a position in ADPT in Q3 2014 and held it in 10 quarters. The position peaked at $1.87M in Q4 2015. 9 funds tracked by Wall St. Rank hold ADPT as of Q2 2017.

  • Credit Suisse reported no remaining Adeptus Health Inc position as of Q2 2017 after selling out during the quarter.
  • Credit Suisse sold 26,160 Adeptus Health Inc shares in Q2 2017, an estimated $47K.
  • Credit Suisse first reported a position in Adeptus Health Inc in Q3 2014 and held it in 10 quarters.
  • Credit Suisse's Adeptus Health Inc position peaked at $1.87M in Q4 2015.
  • 9 funds tracked by Wall St. Rank held Adeptus Health Inc as of Q2 2017.

Based on Credit Suisse's 13F filing for Q2 2017, filed 14 Aug 2017.